UnitedHealth Stock Has Lost Momentum. Will Earnings Turn the Tide?
Key takeaways
- UnitedHealth’s upcoming earnings will decide if the stock can recover from its recent pullback and meet upbeat forecasts.
- UNH stock peaked at $458.80 in July
- UNH fell 17.3% from year‑high
- Medicare Advantage payment increase of 2.48% added ~$13 billion
What happened
UnitedHealth Group (UNH) has seen its stock pull back 17.3% from the year‑high of $458.80 after a strong start in 2026. The decline follows a surge tied to a 2.48% Medicare Advantage payment increase that added roughly $13 billion to the insurer’s revenue. The company will report Q3 results on Tuesday, with analysts expecting revenue of $111.49 billion (range up to $114 billion) and EPS of $4.15 versus $2.92 in Q2.
Why it matters
The earnings release will confirm whether UnitedHealth can sustain its revenue growth and margin expansion after the Medicare bump. A beat could lift the stock back toward the $390 level, while a miss could deepen the sell‑side pressure. The implied volatility spike to 70% reflects market uncertainty about cost and…
Short-term and longer-term
Short-term. Day traders should watch the earnings release for a potential breakout above $390.
Longer-term. Over the next few weeks, investors should assess whether UnitedHealth can maintain its revenue growth trajectory and margin expansion beyond the Medicare bump.